Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status:
Terminated
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of perifosine in treating patients who have
recurrent or metastatic head and neck cancer. Drugs used in chemotherapy such as perifosine
use different ways to stop tumor cells from dividing so they stop growing or die.